购物车
  • TargetMol
    您的购物车当前为空

Nateglinide

一键复制产品信息
Rating icon 很棒

纯度: 99.94%

货号 T1674Cas号 105816-04-4

别名 那格列奈, Senaglinide, A4166

Nateglinide (Senaglinide) 是 D-苯丙氨酸的一种衍生物,是口服有效的、短效促胰岛素释放化合物,也是 DPP IV 抑制剂。 Nateglinide 抑制胰岛 β 细胞中 ATP 敏感的 K+通道。Nateglinide 在 2 型糖尿病中具有研究价值。

Nateglinide
其他形式的 “Nateglinide”:
TargetMol

为众多的药物研发团队赋能,

让新药发现更简单!

Nateglinide

一键复制产品信息
Rating icon 很棒

纯度: 99.94%

货号 T1674 别名 那格列奈, Senaglinide, A4166Cas号 105816-04-4

Nateglinide (Senaglinide) 是 D-苯丙氨酸的一种衍生物,是口服有效的、短效促胰岛素释放化合物,也是 DPP IV 抑制剂。 Nateglinide 抑制胰岛 β 细胞中 ATP 敏感的 K+通道。Nateglinide 在 2 型糖尿病中具有研究价值。

规格价格库存数量
2 mg
¥ 109
现货
5 mg
¥ 169
现货
10 mg
¥ 238
现货
25 mg
¥ 467
现货
50 mg
¥ 762
现货
100 mg
¥ 1,400
现货
200 mg
¥ 1,850
现货
1 mL x 10 mM (in DMSO)
¥ 326
现货
库存状态实时更新,以官网显示为准,现货产品可直接加购物车下单
大包装 & 定制
加入购物车
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
实验操作小课堂
常见问题解答
查看更多
选择批次:
纯度: 99.93%
联系我们 获取更多批次信息

产品介绍


Nateglinide AI Summary
Nateglinide exhibits a range of bioactivities and pharmacokinetic properties. It has notable hypoglycemic activity, reducing blood glucose levels by more than 20% in fasting mice at a dose of 1.6 mg kg^-1 and shows insulin-releasing activity in HIT-T15 cells in high glucose conditions, with activity levels ranging from 36.3% to 124.3% across different concentrations (1 µM, 10 µM, 100 µM). The EC50 for insulin-releasing activity is 7590.0 nM. Pharmacokinetically, Nateglinide demonstrates high bioavailability (F_fraction = 0.72) and good absorption (Fa = 0.9) in humans. It has moderate hepatic (CL = 1.7 mL/min/kg) and renal clearance (CL_renal = 0.1 mL/min/kg) rates, a steady-state volume of distribution (Vdss) of 0.15 L/kg, and an elimination half-life (T1/2) of 1.5 hours. Nateglinide shows inhibitory effects on several transport and enzyme activities. It inhibits OATP1B3 and OATP1B1 transport proteins significantly, with 70.33% and 99.81% inhibition respectively at 10 µM, and also shows inhibitory activity on several transport protein assays, including MRP3 (IC50 = 104000.0 nM). Additionally, Nateglinide displays antiviral activities against SARS-CoV-2, showing an inhibition index of 0.7846 in Vero E6 cells and 2.79% inhibition rate in Caco-2 cells at 10 µM. It inhibits the SARS-CoV-2 3CL-Pro protease by 7.842% at 20 µM and shows some cell viability effects. It also exhibits moderate antihyperglycemic activity in diabetic rats with significant blood glucose reductions at 30.6%, 26.4%, and 13.8% at different time intervals post-administration. Furthermore, it affects various biomarker levels related to liver and kidney functions as well as having potential antifungal and antibacterial activities against Candida albicans, Cryptococcus neoformans, and bacterial strains like E. coli, K. pneumoniae, and S. aureus MRSA. Lastly, Nateglinide's pharmacological profile includes liver toxicity, indicated by a severity class index of 3.0, and potential bioactivity in modulating drug-induced liver injury processes. It also shows significant impacts on insulin secretion, with varying IC50 values under different glucose conditions in INS-1E cells..
Note: Summary generated by AI. Data source: ChEMBL
生物活性
产品描述
Nateglinide (Senaglinide) is an oral hypoglycemic agent and amino acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy of type 2 diabetes. Nateglinide has been linked to rare instances of clinically apparent acute liver injury.
别名那格列奈, Senaglinide, A4166
化学信息
分子量317.42
分子式C19H27NO3
CAS No.105816-04-4
SmilesC(N[C@H](CC1=CC=CC=C1)C(O)=O)(=O)[C@H]2CC[C@H](C(C)C)CC2
密度1.104 g/cm3 (Predicted)
储存&溶解度
存储Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
溶解度信息
DMSO: 60 mg/mL (189.02 mM), Sonication is recommended.
体内实验配方
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (6.3 mM), Sonication is recommended.
请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。
溶液配制表
DMSO
1mg5mg10mg50mg
1 mM3.1504 mL15.7520 mL31.5040 mL157.5200 mL
5 mM0.6301 mL3.1504 mL6.3008 mL31.5040 mL
10 mM0.3150 mL1.5752 mL3.1504 mL15.7520 mL
20 mM0.1575 mL0.7876 mL1.5752 mL7.8760 mL
50 mM0.0630 mL0.3150 mL0.6301 mL3.1504 mL
100 mM0.0315 mL0.1575 mL0.3150 mL1.5752 mL

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
TargetMol | Animal experiments 比如您的给药剂量是10 mg/kg,每只动物体重20g,给药体积100 μLTargetMol | Animal experiments 一共给药动物10只,您使用的配方为5%TargetMol | reagent DMSO + 30%PEG300 + 5%Tween 80 + 60%Saline/PBS/ddH2O, 那么您的工作液浓度为2mg/mL
母液配置方法: 2 mg 药物溶于 50 μLDMSOTargetMol | reagent ( 母液浓度为 40 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:50μLDMSOTargetMol | reagent 母液,添加 300 μLPEG300TargetMol | reagent 混匀澄清,再加 50μLTween80, 混匀澄清,再加 600μLSaline/PBS/ddH2OTargetMol | reagent 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSOPEG300 / PEG400Tween 80SBE-β-CD玉米油 等, 均可在TargetMol网站点击购买。
1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

Related Tags: buy Nateglinide | purchase Nateglinide | Nateglinide cost | order Nateglinide | Nateglinide chemical structure | Nateglinide formula | Nateglinide molecular weight